Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Particulate & foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables.

867 FDA drug recalls with this cause, newest first.

These recalls involve visible foreign material - glass, metal, fibers, rubber or other debris - most often found in injectable or liquid products, where nothing besides the intended ingredients should be present. It also includes foreign tablets or capsules found in a bottle of a different product. In an injectable a stray particle can go straight into the bloodstream, which is why a noticeable share of these recalls are Class I.

Class II · Moderate risk

Glycopyrrolate Tablets

Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.

Terminated Particulate / foreign matter Aurolife Pharma, LLC NDC 13107-014-01 D-0736-2022
Class I · High risk

Sodium Acetate Injection

Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.

Terminated Particulate / foreign matter Fresenius Kabi USA, LLC NDC 63323-032-00 D-0750-2022
Class II · Moderate risk

Chlorthalidone Tablets USP 25 mg

Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup

Terminated Particulate / foreign matter Sun Pharmaceutical Industries INC NDC 57664-648-88 D-0578-2022
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Golden State Medical Supply Inc. D-0227-2022
Class II · Moderate risk

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 43598-743-05 D-0085-2022
Class II · Moderate risk

Carvedilol Tablets

Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle

Terminated Particulate / foreign matter Zydus Pharmaceuticals (USA) Inc NDC 68382-095-05 D-0753-2021
Class I · High risk

Topotecan Injection 4 mg/4mL

Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA NDC 0703-4714-01 D-0661-2021
Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk

Famotidine Tablets USP 40mg

Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

Terminated Particulate / foreign matter Aurobindo Pharma USA Inc. NDC 65862-860-99 D-0290-2021